New research evaluates the effectiveness of abbreviated MRI (AMRI) compared to ultrasound in detecting early-stage hepatocellular carcinoma (HCC). Findings suggest that AMRI significantly outperforms ultrasound in sensitivity and specificity, particularly in patients with obesity, steatotic liver disease (MASLD), or increased liver nodularity, where ultrasound performance is often impaired.
However, both methods showed reduced accuracy in decompensated cirrhosis (Child-Pugh C), emphasizing the potential need for alternative surveillance strategies, such as blood-based biomarkers. As AMRI continues to gain recognition, these findings could influence future HCC surveillance guidelines and improve early detection in high-risk populations.
For more details, refer to the full study:https://lnkd.in/e_gHCxE3
